Cerebrospinal fluid amino acids in relation to neurological status in experimental portal-systemic encephalopathy
- PMID: 1749365
- DOI: 10.1007/BF00999904
Cerebrospinal fluid amino acids in relation to neurological status in experimental portal-systemic encephalopathy
Abstract
Using an indwelling cisterna magna catheter technique, serial CSF samples were analyzed for amino acid content in rats at various stages of portal-systemic encephalopathy resulting from ammonium acetate administration following portacaval anastomosis. Anastomosis alone resulted in increased CSF concentrations of glutamine, tyrosine, phenylalanine, glutamate and alanine. GABA levels, on the other hand were not significantly changed. Onset of severe neurological symptoms following ammonium acetate administration resulted in selectively increased CSF alanine. Other amino acids were not further increased at severe stages of encephalopathy. Increased CSF alanine probably results from increased glutamine transamination in the brains of portacaval shunted rats.
Similar articles
-
Increased cerebrospinal fluid lactate reflects deterioration of neurological status in experimental portal-systemic encephalopathy.Metab Brain Dis. 1991 Dec;6(4):225-31. doi: 10.1007/BF00996922. Metab Brain Dis. 1991. PMID: 1812395
-
Selective alterations of extracellular brain amino acids in relation to function in experimental portal-systemic encephalopathy: results of an in vivo microdialysis study.J Neurochem. 1995 Sep;65(3):1221-8. doi: 10.1046/j.1471-4159.1995.65031221.x. J Neurochem. 1995. PMID: 7643101
-
The effects of ammonia and portal-systemic shunting on brain metabolism, neurotransmission and intracranial hypertension in hyperammonaemia-induced encephalopathy.J Hepatol. 1997 Feb;26(2):387-95. doi: 10.1016/s0168-8278(97)80057-8. J Hepatol. 1997. PMID: 9059962
-
Pathogenesis of hepatic coma.Annu Rev Med. 1975;26:143-57. doi: 10.1146/annurev.me.26.020175.001043. Annu Rev Med. 1975. PMID: 167647 Review. No abstract available.
-
Hyperammonaemia without portal systemic shunting does not resemble hepatic encephalopathy.Adv Exp Med Biol. 1997;420:173-83. doi: 10.1007/978-1-4615-5945-0_11. Adv Exp Med Biol. 1997. PMID: 9286433 Review. No abstract available.
Cited by
-
Tissue-specific alterations of binding sites for peripheral-type benzodiazepine receptor ligand [3H]PK11195 in rats following portacaval anastomosis.Dig Dis Sci. 1994 May;39(5):1055-63. doi: 10.1007/BF02087558. Dig Dis Sci. 1994. PMID: 8174418
-
Increased cerebrospinal fluid lactate reflects deterioration of neurological status in experimental portal-systemic encephalopathy.Metab Brain Dis. 1991 Dec;6(4):225-31. doi: 10.1007/BF00996922. Metab Brain Dis. 1991. PMID: 1812395
-
L-ornithine-L-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of action.Metab Brain Dis. 1998 Jun;13(2):147-57. doi: 10.1023/a:1020613314572. Metab Brain Dis. 1998. PMID: 9699922
-
Effects of hyperammonemia and liver failure on glutamatergic neurotransmission.Metab Brain Dis. 2002 Dec;17(4):237-50. doi: 10.1023/a:1021993431443. Metab Brain Dis. 2002. PMID: 12602501 Review.
-
Is ammonia a pathogenetic factor in Alzheimer's disease?Neurochem Res. 1993 Mar;18(3):235-45. doi: 10.1007/BF00969079. Neurochem Res. 1993. PMID: 8479596 Review.